Glanbia chief: 10% dividend hike doesn't weaken appetite for acquisitions

The company, whose two largest products are Optimum Nutrition and Slimfast, is also committed to its plans for a south Kilkenny cheese plant
Glanbia chief: 10% dividend hike doesn't weaken appetite for acquisitions

Siobhán Talbot, group managing director, said Glanbia continues to look at purchases for both the ingredients side of the business and for its branded goods.

Glanbia said it has weathered the global Covid-19 crisis, with "really strong" first-half earnings paving the way for an increase in a payout to shareholders and a new share buyback plan. 

Net profit after exceptional items rose to €81.3m in the six months from €55.3m a year earlier, as total revenues rose to €2bn from over €1.8bn.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited